Clinical Trials Directory

Trials / Completed

CompletedNCT05761418

Preoperative Vaginal Dinoprostone Versus Misoprostone in Abdominal Myomectomy

Preoperative Vaginal Dinoprostone Versus Misoprostone to Decrease Bleeding During Abdominal Myomectomy

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Beni-Suef University · Academic / Other
Sex
Female
Age
30 Years – 50 Years
Healthy volunteers
Accepted

Summary

Aim and objectives; To compare the efficacy of preoperative administration of dinoprostone 20 mg versus 400 ug misoprostol vaginally in decreasing the amount of bleeding during abdominal myomectomy

Detailed description

Background; Myomectomy is a curative interventional option for many kinds of uterine fibroids, but considerable intraoperative haemorrhage and the necessities for transfusions of blood are still the main challenge for abdomen myomectomy. Aim and objectives; To compare the efficacy of preoperative administration of dinoprostone 20 mg versus 400 ug misoprostol vaginally in decreasing the amount of bleeding during abdominal myomectomy Subjects and methods; This was a prospective randomized double-blind controlled study that included 90 patients complaining of uterine myoma and indicated for myomectomy selected from the outpatient clinic at Beni-suef university hospital

Conditions

Interventions

TypeNameDescription
DRUGDinoprostoneprostaglandin (PG) E2 analog
DRUGMisoprostolprostaglandin (PG) E1 analog

Timeline

Start date
2018-03-01
Primary completion
2023-02-15
Completion
2023-02-20
First posted
2023-03-09
Last updated
2023-03-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05761418. Inclusion in this directory is not an endorsement.